Filament Health Corp. (FLHLF)

0.0450 -0.0050 (-10.00%) At close: 02:54PM EDT

Filament Health Corp.

2900 – 550 Burrard Street
Vancouver, BC V6C 0A3
Canada

https://filament.health

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 11

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Benjamin Lightburn	Co-Founder, CEO & Chairman	126.77k	N/A	1987
Mr. Tom Kineshanko	Co-Founder	126.77k	N/A	1985
Mr. Warren Duncan CPA	Chief Financial Officer	108.66k	N/A	1991
Mr. Jon Conlin	Corp. Sec. & Director	N/A	N/A	1986
Ms. Lisa Ranken	Chief Operating Officer	N/A	N/A	1984
Mr. Ryan Moss	Chief Science Officer	N/A	N/A	N/A
Ms. Anna Cordon	Director of Communications	N/A	N/A	N/A
Mr. Jeff Fellows	Head of Regulatory	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.

Corporate Governance

Filament Health Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.